CFDE Data Portal | Search NPM1P23

	Label	Description
	NPM1P23 associations Collection (Entity type)	Associations for NPM1P23_associations
	NPM1P23 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	NPM1P23 Gene (Entity type)	ENSG00000242109 - nucleophosmin 1 pseudogene 23
	GSE226249 pirfenidone HL 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 7 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE128076 doxycycline HEK293 1 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 3 v 11 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE205714 GSE229013 adenosine 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE143782 calcitriol 6 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

NPM1P23 associations

Associations for NPM1P23_associations

NPM1P23 associations.tsv

A file from IDG as part of the Harmonizome project

NPM1P23

ENSG00000242109 - nucleophosmin 1 pseudogene 23

GSE226249 pirfenidone HL 2 v 1 human up

A Gene Set from LINCS

GSE143782 calcitriol 7 v 11 human dn

A Gene Set from LINCS

GSE128076 doxycycline HEK293 1 v 3 human dn

A Gene Set from LINCS

GSE143782 calcitriol 3 v 11 human dn

A Gene Set from LINCS

GSE205714 GSE229013 adenosine 3 v 2 human dn

A Gene Set from LINCS

GSE143782 calcitriol 6 v 5 human up

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.